ALUR
ALLURION TECHNOLOGIES, INC.Company Information
- Company Name
- ALLURION TECHNOLOGIES, INC.
- CIK
- CIK0001964979
- Category
- <br>Emerging growth company
- Ticker: Exchange
- ALUR: OTC, ALURW: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- ALUR
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-05-19
- Last sale
- 2025-12-04
- Shares purchased (TTM)
- 16,000
- Shares sold (TTM)
- 1,606
Institutional Sentiment
- As of
- 2025-12-31
- Institutional shares owned
- 8,280,873
- Shares outstanding
- 7,544,548
- Ownership
- 109.76%
Earnings Market Reaction
- Filing date
- 2026-05-15
- Price on filing date
- —
- 1-month reaction
- 2.35%
- 3-month reaction
- 405.29%
Balance Sheet
Values in millions ($)| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 5 | 5 | 6 | 13 | 20 | 15 | 29 | 19 | 30 | 38 | 80 | 5 | ||||||
| Accounts Receivable Net Current | 3 | 4 | 4 | 6 | 8 | 7 | 10 | 13 | 16 | 18 | 28 | 26 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 11 | 13 | 15 | 23 | 33 | 27 | 45 | 40 | 54 | 65 | 114 | 37 | ||||||
| Inventory Net | 2 | 3 | 4 | 4 | 3 | 3 | 5 | 5 | 6 | 6 | 4 | 5 | ||||||
| Prepaid Expense And Other Assets Current | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 2 | 2 | 2 | 2 | ||||||
| Property Plant And Equipment Net | 1 | 1 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | ||||||
| Operating Lease Right Of Use Asset | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | ||||||
| Other Assets Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 9 | ||||||
| Assets | 14 | 16 | 18 | 28 | 38 | 33 | 51 | 47 | 60 | 72 | 121 | 52 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable Current | 3 | 4 | 3 | 4 | 5 | 7 | 10 | 8 | 12 | 10 | 9 | 15 | ||||||
| Long Term Debt Current | - | - | - | - | - | - | - | - | 39 | 39 | 58 | 54 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 37 | 38 | 12 | 12 | 16 | 19 | 19 | 24 | 66 | 65 | 87 | 90 | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | ||||||
| Accounts Payable And Other Accrued Liabilities Current | 5 | 6 | 8 | 7 | 10 | 11 | 8 | 15 | 15 | 15 | 19 | 21 | ||||||
| Convertible Notes Payable Current | 29 | 28 | - | - | - | 0 | - | - | - | - | - | - | ||||||
| Warrants And Rights Outstanding | 5 | 6 | 6 | 7 | 9 | 5 | 7 | 2 | 3 | 7 | 12 | - | ||||||
| Business Combination Contingent Consideration Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 4 | 10 | 24 | 29 | 53 | ||||||
| Convertible Long Term Notes Payable | - | 0 | 32 | 29 | 31 | 36 | 36 | 41 | - | - | - | 20 | ||||||
| Operating Lease Liability Noncurrent | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 3 | 3 | ||||||
| Other Liabilities Noncurrent | 0 | 0 | 1 | 1 | 1 | 0 | 10 | 6 | 10 | 8 | 6 | 11 | ||||||
| Liabilities | 92 | 93 | 101 | 92 | 108 | 111 | 115 | 117 | 126 | 143 | 173 | 123 | ||||||
Redeemable Noncontrolling Interest Equity Carrying Amount | ||||||||||||||||||
| Redeemable Noncontrolling Interest Equity Carrying Amount | - | - | - | - | - | - | - | - | - | - | 0 | 39 | ||||||
| Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value | - | - | - | - | - | - | - | - | - | - | - | 58 | ||||||
Temporary Equity | ||||||||||||||||||
| Temporary Equity Carrying Amount Attributable To Parent | - | - | - | - | - | - | 1 | - | - | - | - | - | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Stockholders Equity | -78 | -77 | -83 | -64 | -70 | -78 | -65 | -71 | -66 | -71 | -53 | -71 | ||||||
| Additional Paid In Capital | 173 | 169 | 163 | 163 | 158 | 153 | 151 | 145 | 144 | 143 | 141 | 15 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 6 | 5 | -1 | 6 | -4 | -8 | -3 | 6 | 3 | 1 | - | - | ||||||
| Retained Earnings Accumulated Deficit | -257 | -251 | -245 | -233 | -224 | -222 | -213 | -221 | -213 | -215 | -194 | -172 | ||||||
| Convertible Preferred Stock Series A A1 B D1 D2 D3 | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Liabilities And Stockholders Equity | 14 | 16 | 18 | 28 | 38 | 33 | 51 | 47 | 60 | 72 | 121 | 52 | ||||||
| Series C Redeemable Convertible Preferred Stock | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Allowance For Doubtful Accounts Premiums And Other Receivables | 5 | 5 | 8 | 7 | 6 | 7 | 8 | 11 | 13 | 13 | 6 | 4 | ||||||
| Temporary Equity Par Or Stated Value Per Share | - | - | - | - | - | - | 0.00 | - | - | - | - | - | ||||||
| Temporary Equity Shares Authorized | - | - | - | - | - | - | 100 | - | - | - | - | - | ||||||
| Temporary Equity Shares Issued | - | - | - | - | - | - | 2 | - | - | - | - | - | ||||||
| Temporary Equity Shares Outstanding | - | - | - | - | - | - | 2 | - | - | - | - | - | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | 0.00 | 0.00 | 0.00 | 0.00 | - | ||||||
| Preferred Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 21 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 20 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 20 | ||||||
| Preferred Stock Liquidation Preference Value | - | - | - | - | - | - | - | - | - | - | - | 131 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 38 | ||||||
| Common Stock Shares Issued | 15 | 12 | 8 | 8 | 6 | 3 | 3 | 2 | 2 | 2 | 2 | 0 | ||||||
| Shares Outstanding | 15 | 12 | 8 | 8 | 6 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialALLURION TECHNOLOGIES, INC. (ALUR) — SEC Financial Statements & Analysis
ALLURION TECHNOLOGIES, INC. (ALUR) is a surgical & medical instruments & apparatus company, incorporated in DE. ALLURION TECHNOLOGIES, INC. trades on OTC as: ALUR, ALURW. ALLURION TECHNOLOGIES, INC. (ALUR)'s most recent SEC filing is a Form 10-Q for the period ended 2026-03-31, filed with the SEC on 2026-05-15. Based on that filing, ALLURION TECHNOLOGIES, INC. carries a market cap of $9.01M, a P/E ratio of -0.27x, a P/B ratio of -0.12x, a P/S ratio of 0.72x, an enterprise value of $32.51M, and an EV/EBITDA multiple of -1.27x. On profitability, it posts a gross margin of 52.70%, an operating margin of -211.21%, a net margin of -264.74%, a Return on Equity (ROE) of 45.16%, and a Return on Assets (ROA) of -127.26%. Per share, it reports EPS of $-2.50, diluted EPS of $-2.50, free cash flow per share of $-1.70, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -55.49% year-over-year, net income growth of 12.49% year-over-year, and EPS growth of -59.74% year-over-year. On the balance sheet, it maintains a current ratio of 0.30x, a quick ratio of 0.23x, working capital of $-25.95M, a debt-to-equity ratio of -1.18x, a debt ratio of 6.57, an interest coverage ratio of -6830.83x, free cash flow of $-22.70M (TTM), and net debt of $23.49M. Figures sourced from SEC EDGAR.
- Market Cap
- $9.01M
- P/E TTM
- -0.27x
- EPS TTM
- $-2.50
- P/B TTM
- -0.12x
- ROE TTM
- 45.16%
- ROA TTM
- -127.26%
- Debt To Equity
- -1.18x
- Free Cash Flow TTM
- $-22.70M
- Net Revenue TTM Growth 1Y
- -55.49%
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is ALLURION TECHNOLOGIES, INC. in?
ALLURION TECHNOLOGIES, INC. (ALUR) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does ALUR trade on?
ALLURION TECHNOLOGIES, INC. (ALUR) trades on the OTC.
Where is ALLURION TECHNOLOGIES, INC. incorporated?
ALLURION TECHNOLOGIES, INC. is incorporated in DE.
When was ALLURION TECHNOLOGIES, INC. (ALUR)'s most recent SEC filing?
ALLURION TECHNOLOGIES, INC. (ALUR)'s most recent SEC filing is a Form 10-Q for the period ended 2026-03-31, filed with the SEC on 2026-05-15.
What is ALUR's market cap?
ALLURION TECHNOLOGIES, INC. (ALUR) has a market capitalization of $9.01M as of 2026-03-31.
What is ALUR's EPS (earnings per share)?
ALLURION TECHNOLOGIES, INC. (ALUR)'s trailing twelve month EPS is $-2.50 as of 2026-03-31.
What is ALUR's ROE (return on equity)?
ALLURION TECHNOLOGIES, INC. (ALUR)'s trailing twelve month Return on Equity (ROE) is 45.16% as of 2026-03-31.
What is ALUR's ROA (return on assets)?
ALLURION TECHNOLOGIES, INC. (ALUR)'s trailing twelve month Return on Assets (ROA) is -127.26% as of 2026-03-31.
What is ALUR's EV/EBITDA?
ALLURION TECHNOLOGIES, INC. (ALUR)'s trailing twelve month EV/EBITDA is -1.27x as of 2026-03-31.